6-Fluorospiro[4H-3,1-benzoxazine-4,4'-piperidin]-2(1H)-one, 95.0%, 1g

(S)-methyl 2-((tert-butoxycarbonyl)amino)-3-(4-carbamoyl-2,6-dimethylphenyl)propanoate, 96%, 250mg

2-Bromo-1-(3-chloro-4-fluorophenyl)ethanone, 95.0%, 5g

2-Methoxycyclohepta-2,4,6-trienone, 97%, 1g

2-Phenoxy-N-methylethylamine hydrochloride, 95.0%, 5g

Glass packaging wool 25 µm, from chem. durable glass packaging, DIN 1259-1, 500 g, plastic packaging.

4-Bromo-5-methylthiophene-2-carboxylic acid, 95.0%, 5g

Adamantane-1,3-diyldimethanol, 95.0%, 250mg

10-Methoxy-5H-dibenzo[b,f]azepine-5-carboxamide, 95.0%, 10g

1-[bromomethyl(ethoxy)phosphoryl]oxyethane, 98%, 25g

(R)-4-Isopropyl-3-propionyloxazolidin-2-one, 95.0%, 250mg

(R)-3-(4-Fluoro-2-nitrophenoxy)pyrrolidine hydrochloride, 95.0%, 1g

2-Methyl-3-furanthiol>95.0%(GC)1g